SABBY MANAGEMENT, LLC
Q2 2025 13F Holdings
- Locationmiami beach, FL
- Num holdings
43
- Value ($000)
$55,146
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001535610
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
ISHARES TR | ETF | 464287955 | $18.34M | 33 % | 850 | put | |
SPDR S&P 500 ETF | ETF | 78462F953 | $11.49M | 21 % | 186 | put | |
SPDR S&P 500 ETF | ETF | 78462F903 | $6.18M | 11 % | 100 | call | |
EOS ENERGY ENTERPRISES INC | CL A | 29415C951 | $3.94M | 7 % | 7,704 | put | |
TEMPEST THERAPEUTICS INC | COM | 87978U207 | $1.88M | 3 % | 276,587 | ||
EOSE EOS ENERGY ENTERPRISES INC | CL A | 29415C101 | $1.75M | 3 % | 342,303 | ||
LYRA THERAPEUTICS INC | COM | 55234L204 | $1.13M | 2 % | 125,729 | ||
CORE SCIENTIFIC INC | COM | 21874A906 | $1.08M | 2 % | 631 | call | |
LXX LEXARIA BIOSCIENCE CORP | COM | 52886N406 | $1.01M | 2 % | 1,165,144 | ||
CANF CAN-FITE BIOPHARMA LTD | ADR | 13471N300 | $818.73K | 2 % | 779,744 |
Rows Per Page
10
- 10
- 50
- 100